Stock Analiz

Picard Medical, Inc. PMI

Medical/Dental Instruments · IPO 2025 · data as of November 13, 2026

$7.23Market cap $18M
Open the interactive analysis →

Picard Medical, Inc. (PMI) is a healthcare company listed in the US with a market value of about $18M. In the twelve months to June 30, 2026 it had revenue of $6M and net income of -$28M, a net margin of -444.3%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -249%.

About Picard Medical

Picard Medical is listed in the US and classified in medical/dental instruments, IPO year 2025. It was profitable in 0 of the last 2 years in our data. It spends 62% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth2/5
Track record0/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2.8
P/B10.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-90.2%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)12.5%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-513.0%
ROIC (5-yr avg.)-248.8%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 2 years

Fiscal yearTTM20252024
Revenue$6M$5M$4M
Net income-$28M-$27M-$21M
Free cash flow-$16M-$16M-$12M
EPS (diluted)$-3.13$-0.75$-2.99
Net margin-444.3%-546.6%-479.5%
ROIC—-248.8%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Picard Medical pay a dividend?

Not currently.

Is Picard Medical a good stock to buy?

We do not give buy or sell advice. Picard Medical scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.